Alzheimer's disease and Parkinson's disease are neurodegenerative disorders that affect the central nervous system, albeit in distinct ways. Alzheimer's primarily manifests with memory loss, cognitive decline, and behavioral changes due to the buildup of amyloid plaques and tau protein tangles in the brain. On the other hand, Parkinson's disease is characterized by motor symptoms like tremors, stiffness, and impaired movement caused by the loss of dopamine-producing neurons in the brain's substantia nigra.
Both diseases share some similarities in terms of their impact on brain function and quality of life. However, their pathophysiology, symptoms, and progression differ significantly. Alzheimer's tends to affect memory and cognition first, while Parkinson's often begins with motor symptoms. Research into treatments and potential cures for these conditions continues to evolve, aiming to alleviate symptoms and improve the lives of those affected by these challenging diseases.
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cogs Club: Making a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States